Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-089391
Filing Date
2024-08-01
Accepted
2024-08-01 16:54:46
Documents
1
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10154
  Complete submission text file 0000950170-24-089391.txt   11864
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921
Business Address
Berg Aaron (Reporting) CIK: 0001770259 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 241167584